Skip to main content
Top
Published in: BMC Nephrology 1/2013

Open Access 01-12-2013 | Research article

The relationship between obesity and diabetic nephropathy in China

Authors: Hui-Mei Chen, Wen-Wen Shen, Yong-Chun Ge, Yi-De Zhang, Hong-Lang Xie, Zhi-Hong Liu

Published in: BMC Nephrology | Issue 1/2013

Login to get access

Abstract

Background

The epidemic of diabetic nephropathy (DN) has been paralleled by rapid increases in both obesity and diabetes in China. The aim of this study was to investigate the natural history of DN and the association of obesity and renal function with diabetes.

Methods

In total, 264 patients with renal biopsy-confirmed DN were examined from 2002 to 2008 and followed up to June 2008 in our institute. Among these, 129 patients were classified into a Kidney Disease Outcomes Quality Initiative (K/DOQI) stage I subgroup. Weight status, clinico-histopathological features, the development of end-stage renal disease (ESRD) and increased proteinuria were evaluated at the baseline of biopsy and during the follow up. Lean, overweight and obese phenotypes were defined as body mass index (BMI) less than 25 kg/m2, 25–28 kg/m2, and more than 28 kg/m2 over, respectively.

Results

In the patients with renal biopsy-confirmed DN, BMI was 25.5 ± 3.39 kg/m2, with 122 (46.2%), 83 (31.4%) and 59 (22.3%) having lean, overweight and obese phenotypes, respectively. Mean proteinuria was 3.09 ± 2.32 g/24 h, serum creatinine was 2.02 ± 2.02 mg/dL, and creatinine clearance rate (Ccr) was 96.0 ± 54.0 mL/min/1.73 m2. Compared with obese patients, lean patients had a lower Ccr, a higher percentage of anemia, more renal lesions and higher risk for ESRD (HR = 1.812, P = 0.048). The weight in obese patients decreased significantly after 27 months, and lean patients had a longer duration of diabetes than obese patients. Regarding patients at K/DOQI stage I, patients with DN showed similar duration of diabetes regardless of weight status. Minimal weight loss was recorded in obese patients during follow-up, and they exhibited greater glomerular hyperfiltration and higher risk for increased proteinuria (HR = 2.872, P = 0.014) than lean patients.

Conclusions

In China, obesity is common in DN patients undergoing biopsy. Initial high levels of proteinuria and subsequent weight loss are the major characteristics of the natural course of DN. Obesity contributed to increased proteinuria at an early stage, while the lean phenotype was associated with ESRD development, especially at the later stages.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ji CY, Cheng TO: Epidemic increase in overweight and obesity in Chinese children from 1985 to 2005. Int J Cardiol. 2009, 132 (1): 1-10. 10.1016/j.ijcard.2008.07.003.CrossRefPubMed Ji CY, Cheng TO: Epidemic increase in overweight and obesity in Chinese children from 1985 to 2005. Int J Cardiol. 2009, 132 (1): 1-10. 10.1016/j.ijcard.2008.07.003.CrossRefPubMed
2.
go back to reference Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS: Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006, 144 (1): 21-28.CrossRefPubMed Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS: Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006, 144 (1): 21-28.CrossRefPubMed
3.
go back to reference Hsieh MC, Hsieh YT, Cho TJ, Chen JF, Lin SD, Chen HC, Tu ST: Remission of diabetic nephropathy in type 2 diabetic Asian population: role of tight glucose and blood pressure control. Eur J Clin Invest. 2011, 41 (8): 870-878. 10.1111/j.1365-2362.2011.02479.x.CrossRefPubMed Hsieh MC, Hsieh YT, Cho TJ, Chen JF, Lin SD, Chen HC, Tu ST: Remission of diabetic nephropathy in type 2 diabetic Asian population: role of tight glucose and blood pressure control. Eur J Clin Invest. 2011, 41 (8): 870-878. 10.1111/j.1365-2362.2011.02479.x.CrossRefPubMed
4.
go back to reference Luk A, Chan JC: Diabetic nephropathy–what are the unmet needs?. Diabetes Res Clin Pract. 2008, 82 (Suppl 1): S15-S20.CrossRefPubMed Luk A, Chan JC: Diabetic nephropathy–what are the unmet needs?. Diabetes Res Clin Pract. 2008, 82 (Suppl 1): S15-S20.CrossRefPubMed
5.
go back to reference Speakman JR, Westerterp KR: Reverse epidemiology, obesity and mortality in chronic kidney disease: modelling mortality expectations using energetics. Blood Purif. 2010, 29 (2): 150-157. 10.1159/000245642.CrossRefPubMed Speakman JR, Westerterp KR: Reverse epidemiology, obesity and mortality in chronic kidney disease: modelling mortality expectations using energetics. Blood Purif. 2010, 29 (2): 150-157. 10.1159/000245642.CrossRefPubMed
6.
go back to reference Valocikova I, Valocik G, Kristofova B, Druzbacka L: Obesity paradox and chronic kidney disease. Bratisl Lek Listy. 2011, 112 (7): 402-406.PubMed Valocikova I, Valocik G, Kristofova B, Druzbacka L: Obesity paradox and chronic kidney disease. Bratisl Lek Listy. 2011, 112 (7): 402-406.PubMed
7.
go back to reference Pei YP, Greenwood CM, Chery AL, Wu GG: Racial differences in survival of patients on dialysis. Kidney Int. 2000, 58 (3): 1293-1299. 10.1046/j.1523-1755.2000.00285.x.CrossRefPubMed Pei YP, Greenwood CM, Chery AL, Wu GG: Racial differences in survival of patients on dialysis. Kidney Int. 2000, 58 (3): 1293-1299. 10.1046/j.1523-1755.2000.00285.x.CrossRefPubMed
8.
go back to reference Zhou BF: Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults–study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci. 2002, 15 (1): 83-96.PubMed Zhou BF: Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults–study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci. 2002, 15 (1): 83-96.PubMed
9.
go back to reference Li LS, Liu ZH: Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies. Kidney Int. 2004, 66 (3): 920-923. 10.1111/j.1523-1755.2004.00837.x.CrossRefPubMed Li LS, Liu ZH: Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies. Kidney Int. 2004, 66 (3): 920-923. 10.1111/j.1523-1755.2004.00837.x.CrossRefPubMed
10.
go back to reference Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998, 15 (7): 539-553. 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.CrossRefPubMed Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998, 15 (7): 539-553. 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.CrossRefPubMed
11.
go back to reference Jennette JLO JC, Schwartz MM, Silva FG: Heptinstall’s Pathology of the Kidney. 1998, Lippincott Willians & Wirkins, 5 Jennette JLO JC, Schwartz MM, Silva FG: Heptinstall’s Pathology of the Kidney. 1998, Lippincott Willians & Wirkins, 5
12.
go back to reference Huang F, Yang Q, Chen L, Tang S, Liu W, Yu X: Renal pathological change in patients with type 2 diabetes is not always diabetic nephropathy: a report of 52 cases. Clin Nephrol. 2007, 67 (5): 293-297.CrossRefPubMed Huang F, Yang Q, Chen L, Tang S, Liu W, Yu X: Renal pathological change in patients with type 2 diabetes is not always diabetic nephropathy: a report of 52 cases. Clin Nephrol. 2007, 67 (5): 293-297.CrossRefPubMed
13.
go back to reference Tone A, Shikata K, Matsuda M, Usui H, Okada S, Ogawa D, Wada J, Makino H: Clinical features of non-diabetic renal diseases in patients with type 2 diabetes. Diabetes Res Clin Pract. 2005, 69 (3): 237-242. 10.1016/j.diabres.2005.02.009.CrossRefPubMed Tone A, Shikata K, Matsuda M, Usui H, Okada S, Ogawa D, Wada J, Makino H: Clinical features of non-diabetic renal diseases in patients with type 2 diabetes. Diabetes Res Clin Pract. 2005, 69 (3): 237-242. 10.1016/j.diabres.2005.02.009.CrossRefPubMed
14.
go back to reference Lemann J, Bidani AK, Bain RP, Lewis EJ, Rohde RD: Use of the serum creatinine to estimate glomerular filtration rate in health and early diabetic nephropathy. Collaborative study group of angiotensin converting enzyme inhibition in diabetic nephropathy. Am J Kidney Dis. 1990, 16 (3): 236-243.CrossRefPubMed Lemann J, Bidani AK, Bain RP, Lewis EJ, Rohde RD: Use of the serum creatinine to estimate glomerular filtration rate in health and early diabetic nephropathy. Collaborative study group of angiotensin converting enzyme inhibition in diabetic nephropathy. Am J Kidney Dis. 1990, 16 (3): 236-243.CrossRefPubMed
15.
go back to reference Chen HM, Chen Y, Zhang YD, Zhang PP, Chen HP, Wang QW, Li LS, Liu ZH: Evaluation of metabolic risk marker in obesity-related glomerulopathy. J Ren Nutr. 2011, 21 (4): 309-315. 10.1053/j.jrn.2010.06.019.CrossRefPubMed Chen HM, Chen Y, Zhang YD, Zhang PP, Chen HP, Wang QW, Li LS, Liu ZH: Evaluation of metabolic risk marker in obesity-related glomerulopathy. J Ren Nutr. 2011, 21 (4): 309-315. 10.1053/j.jrn.2010.06.019.CrossRefPubMed
16.
go back to reference Lane PH, Steffes MW, Mauer SM: Estimation of glomerular volume: a comparison of four methods. Kidney Int. 1992, 41 (4): 1085-1089. 10.1038/ki.1992.165.CrossRefPubMed Lane PH, Steffes MW, Mauer SM: Estimation of glomerular volume: a comparison of four methods. Kidney Int. 1992, 41 (4): 1085-1089. 10.1038/ki.1992.165.CrossRefPubMed
17.
go back to reference Chen HM, Liu ZH, Zeng CH, Li SJ, Wang QW, Li LS: Podocyte lesions in patients with obesity-related glomerulopathy. Am J Kidney Dis. 2006, 48 (5): 772-779. 10.1053/j.ajkd.2006.07.025.CrossRefPubMed Chen HM, Liu ZH, Zeng CH, Li SJ, Wang QW, Li LS: Podocyte lesions in patients with obesity-related glomerulopathy. Am J Kidney Dis. 2006, 48 (5): 772-779. 10.1053/j.ajkd.2006.07.025.CrossRefPubMed
18.
go back to reference Gellman DD, Pirani CL, Soothill JF, Muehrcke RC, Kark RM: Diabetic nephropathy: a clinical and pathologic study based on renal biopsies. Medicine (Baltimore). 1959, 38: 321-367.CrossRef Gellman DD, Pirani CL, Soothill JF, Muehrcke RC, Kark RM: Diabetic nephropathy: a clinical and pathologic study based on renal biopsies. Medicine (Baltimore). 1959, 38: 321-367.CrossRef
19.
go back to reference Weight loss helps type 2 diabetes patients. Dis Manag Advis. 2008, 14 (10): 11-12. Weight loss helps type 2 diabetes patients. Dis Manag Advis. 2008, 14 (10): 11-12.
20.
go back to reference Ramachandran A, Ma RC, Snehalatha C: Diabetes in Asia. Lancet. 2010, 375 (9712): 408-418. 10.1016/S0140-6736(09)60937-5.CrossRefPubMed Ramachandran A, Ma RC, Snehalatha C: Diabetes in Asia. Lancet. 2010, 375 (9712): 408-418. 10.1016/S0140-6736(09)60937-5.CrossRefPubMed
23.
go back to reference Meltzer AA, Everhart JE: Unintentional weight loss in the United States. Am J Epidemiol. 1995, 142 (10): 1039-1046.PubMed Meltzer AA, Everhart JE: Unintentional weight loss in the United States. Am J Epidemiol. 1995, 142 (10): 1039-1046.PubMed
24.
go back to reference Shen WW, Chen HM, Chen H, Xu F, Li LS, Liu ZH: Obesity-related glomerulopathy: body mass index and proteinuria. Clin J Am Soc Nephrol. 2010, 5 (8): 1401-1409. 10.2215/CJN.01370210.CrossRefPubMedPubMedCentral Shen WW, Chen HM, Chen H, Xu F, Li LS, Liu ZH: Obesity-related glomerulopathy: body mass index and proteinuria. Clin J Am Soc Nephrol. 2010, 5 (8): 1401-1409. 10.2215/CJN.01370210.CrossRefPubMedPubMedCentral
25.
go back to reference Saiki A, Nagayama D, Ohhira M, Endoh K, Ohtsuka M, Koide N, Oyama T, Miyashita Y, Shirai K: Effect of weight loss using formula diet on renal function in obese patients with diabetic nephropathy. Int J Obes (Lond). 2005, 29 (9): 1115-1120. 10.1038/sj.ijo.0803009.CrossRef Saiki A, Nagayama D, Ohhira M, Endoh K, Ohtsuka M, Koide N, Oyama T, Miyashita Y, Shirai K: Effect of weight loss using formula diet on renal function in obese patients with diabetic nephropathy. Int J Obes (Lond). 2005, 29 (9): 1115-1120. 10.1038/sj.ijo.0803009.CrossRef
26.
go back to reference Andreotti F, Rio T, Lavorgna A: Body fat and cardiovascular risk: understanding the obesity paradox. Eur Heart J. 2009, 30 (7): 752-754.CrossRefPubMed Andreotti F, Rio T, Lavorgna A: Body fat and cardiovascular risk: understanding the obesity paradox. Eur Heart J. 2009, 30 (7): 752-754.CrossRefPubMed
27.
go back to reference Zoccali C: The obesity epidemics in ESRD: from wasting to waist?. Nephrol Dial Transplant. 2009, 24 (2): 376-380.CrossRefPubMed Zoccali C: The obesity epidemics in ESRD: from wasting to waist?. Nephrol Dial Transplant. 2009, 24 (2): 376-380.CrossRefPubMed
28.
go back to reference Wang Y: Medicine. 2010, Houst, co: People’s Medical Publish Wang Y: Medicine. 2010, Houst, co: People’s Medical Publish
29.
go back to reference Chen HM, Li SJ, Chen HP, Wang QW, Li LS, Liu ZH: Obesity-related glomerulopathy in China: a case series of 90 patients. Am J Kidney Dis. 2008, 52 (1): 58-65. 10.1053/j.ajkd.2008.02.303.CrossRefPubMed Chen HM, Li SJ, Chen HP, Wang QW, Li LS, Liu ZH: Obesity-related glomerulopathy in China: a case series of 90 patients. Am J Kidney Dis. 2008, 52 (1): 58-65. 10.1053/j.ajkd.2008.02.303.CrossRefPubMed
Metadata
Title
The relationship between obesity and diabetic nephropathy in China
Authors
Hui-Mei Chen
Wen-Wen Shen
Yong-Chun Ge
Yi-De Zhang
Hong-Lang Xie
Zhi-Hong Liu
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2013
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-14-69

Other articles of this Issue 1/2013

BMC Nephrology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.